MEDXF - Medexus Pharmaceuticals (TSX.V: MDP) (OTCQX: MEDXF) Featured in Coverage of Sidoti's Virtual Microcap Conference
Medexus Pharmaceuticals Inc. (TSX.V: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is a leading innovative and rare disease company with a strong North American commercial platform. From a foundation of proven best in class products, Medexus is building a highly differentiated company with a portfolio of innovative and high value orphan and rare disease products that will underpin its growth for the next decade. The Company's vision is to provide the best healthcare products to health care professionals and patients, through its core values of quality, innovation, customer service and teamwork. For more information, please visit the company's website at www.medexus.com.
To view IBN’s virtual coverage of Medexus Pharmaceuticals and other presenters at the Sidoti Microcap Conference, as well as gain access to additional conference information and registration, visit https://ibn.fm/SidotiMay2021Portal.
Institutional, family office and high-net-worth investors, as well as RIAs, who wish to schedule a 1x1 meeting with the management of Medexus can contact the Sidoti conference team directly at conference@sidoti.com.
To view IBN’s virtual coverage of the Sidoti Virtual Microcap Conference, visit https://ibn.fm/SidotiMay2021Portal
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at the Sidoti Virtual Microcap Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com